RT Journal Article
SR Electronic
T1 Characterizing co-occurring conditions by age at diagnosis in autism spectrum disorders
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19002527
DO 10.1101/19002527
A1 Michelle D. Failla
A1 Kyle L. Schwartz
A1 Shikha Chaganti
A1 Laurie E. Cutting
A1 Bennett A. Landman
A1 Carissa J. Cascio
YR 2019
UL http://medrxiv.org/content/early/2019/07/19/19002527.abstract
AB Individuals with autism spectrum disorders (ASD) experience a significant number of co-occurring medical conditions, yet little is known about these conditions beyond prevalence. We hypothesized that individuals with ASD experienced an increased burden of co-occurring conditions as measured by presence, frequency, and duration of visits related to co-occurring conditions. We expected that age of ASD diagnosis (early, <7; late, >7) would be associated with different co-occurring conditions. Medical record data were extracted from a large anonymized medical center database for 3097 individuals with ASD and 3097 matched controls. Co-occurring conditions were characterized using a novel tool (pyPheWAS) to examine presence, frequency, and duration of each condition. We identified several categories of co-occurring conditions in ASD: neurological (epilepsy, sleep disorders); psychiatric (mood disorders, adjustment/conduct disorders, suicidal ideation), and developmental. Early ASD diagnosis was associated with epilepsy-related conditions, whereas a later diagnosis was associated with psychiatric conditions. The early ASD diagnosis group had later first diagnosis of co-occurring psychiatric conditions compared to the late ASD diagnosis group. Our work confirms individuals with ASD are under a significant medical burden, with increased duration and frequency of visits associated with co-occurring conditions. Adequate management of these conditions could reduce burden on individuals with ASD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe datasets used for the analyses described were obtained from Vanderbilt University Medical Center?s BioVU which is supported by numerous sources: institutional funding, private agencies, and federal grants. These include the NIH funded Shared Instrumentation Grant S10RR025141; and CTSA grants UL1TR002243, UL1TR000445, and UL1RR024975. Dr. Failla was supported by a NIMH training grant (T32-MH18921) during completion of this work. This work was also supported in part by the National Institute of Biomedical Imaging and Bioengineering training grant T32-EB021937 and by Eunice Kennedy Shriver National Institute of Child Health & Human Development grant U54HD08321105.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableThe datasets used for the analyses described were obtained from Vanderbilt University Medical Center?s BioVU and are not available for distribution.